News

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and ...
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
If you’re struggling with your body image this summer, there is still time to reach your image goals. Robert Andrews Laser & Medical Aesthetics is here to help you out this summer.